Epcoritamab plus R-CHOP in patients with previously untreated (1L) high-risk diffuse large b-cell lymphoma, including double-hit/triple-hit lymphoma: updated EPCORE NHL-2 data
Falchi, L Clausen, MR Offner, F de Vos, S Brody, J Linton, Kim M Snauwaert, S Cordoba, R Wu, J Bykhovski, I
Falchi, L
Clausen, MR
Offner, F
de Vos, S
Brody, J
Linton, Kim M
Snauwaert, S
Cordoba, R
Wu, J
Bykhovski, I
Citations
Altmetric:
Abstract
Description
Date
2023
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Falchi L, Clausen MR, Offner F, de Vos S, Brody J, Linton KM, et al. Epcoritamab plus R-CHOP in Patients With Previously Untreated (1L) High-Risk Diffuse Large B-Cell Lymphoma, Including Double-Hit/Triple-Hit Lymphoma: Updated EPCORE NHL-2 Data. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2023 SEP;23:S431-S2. PubMed PMID: WOS:001062479600452. English.